Biomeasure, Incorporated
Records under this name other than the patents Biomeasure, Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Biomeasure, Incorporated
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,458,195 | Melanocortin Receptor Ligands Formerly held In force · High confidence | In force | High confidence | |
| US 9,758,549 | Melanocortin Receptor Ligands Modified with Hydantoin Formerly held In force · High confidence | In force | High confidence | |
| US 9,439,943 | Use of Melanocortins to Treat Insulin Sensitivity Formerly held In force · High confidence | In force | High confidence | |
| US 9,827,286 | Use of Melanocortins to Treat Insulin Sensitivity Formerly held In force · High confidence | In force | High confidence | |
| US 9,296,783 | Melanocortin Receptor Ligands Modified with Hydantoin Formerly held In force · High confidence | In force | High confidence | |
| US 8,563,000 | Melanocortin Receptor Ligands Modified with Hydantoin Formerly held In force · High confidence | In force | High confidence | |
| US 9,155,777 | Use of Melanocortins to Treat Insulin Sensitivity Formerly held In force · High confidence | In force | High confidence | |
| US 8,871,706 | Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,053,500 | Variant of Antihemophilic Factor VIII Having Increased Specific Activity Formerly held In force · High confidence | In force | High confidence | |
| US 8,039,435 | Melanocortin Receptor Ligands Formerly held In force · High confidence | In force | High confidence |